Science Arts rises further as Nagoya City Disaster Prevention and Crisis Management Bureau adopts approximately 1,000 IDs of 'Buddycom'
Science Arts, Inc. <4412> extended gains in afternoon trading after announcing around 11:30 a.m. that the Nagoya City Disaster Prevention and Crisis Management Bureau adopted about 1,000 IDs of its live communication platform Buddycom, sparking buying interest.
Buddycom uses internet networks to enable simultaneous communication among multiple users - similar to walkie-talkies or wireless radios - via a smartphone or tablet app. The platform is used across various industries, including aviation, railways, construction, welfare facilities, and distribution.
Source: MINKABU PRESS
*Translated by generative AI. Click here for the original article.
Related Articles
-
SUMITOMO CHEMICAL extends gains after developing LCP filament for 3D printers
Tue Sep 1, 2026 2:16 pm JST Catalyst -
Advancing and declining issues on TSE Prime market as of 2:00 p.m.
Tue Sep 1, 2026 2:04 pm JST Market -
eSOL ranks 3rd in 'rising sell forecasts' among individual investors on Minkab
Tue Sep 1, 2026 2:16 pm JST Catalyst -
INPEX recovers 4,000-yen level as WTI crude rises above $87 on Iran tensions
Tue Sep 1, 2026 2:12 pm JST Catalyst -
Mitsubishi UFJ Financial Group and other bank stocks hold firm as long-term interest rates top 3% for first time in 30 years
Tue Sep 1, 2026 1:49 pm JST Catalyst -
MUROMACHI CHEMICALS shares firm as company announces plan to open chemical development center
Tue Sep 1, 2026 1:49 pm JST Catalyst -
RICOH hits new year-to-date high after announcing physical AI technology applicable to various robots
Tue Sep 1, 2026 1:45 pm JST Catalyst -
Terra Drone tops 'rising buy forecasts' ranking on Minkabu
Tue Sep 1, 2026 1:33 pm JST Catalyst -
Tri Chemical Laboratories falls for third straight session despite upward revision to FY2027 January-term earnings forecast
Tue Sep 1, 2026 1:32 pm JST Catalyst -
HEALIOS rebounds after obtaining manufacturing and marketing approval license for regenerative medicine products
Tue Sep 1, 2026 1:08 pm JST Catalyst